No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Are clinical trial sites unfairly bearing the brunt of trial failures?
There has been a spotlight on improving patient recruitment and retention as the industry recognises the value of patient-centricity.
Ventyx scraps TYK2 inhibitor after Phase II Crohn’s defeat
Ventyx no longer plans to conduct additional clinical trials of VTX958 with internal resources after the Phase II trial missed its primary endpoint.
What does Biden’s executive order mean for worldwide AI regulation?
Regulators worldwide are designing and implementing AI legislation to keep up with technology’s pace of development.
Clear Clinical Trial Information is the Key to Patient Engagement
Deborah Collyar, Patient Advocates in Research (PAIR) and Catina O’Leary, Health Literacy Media, show why public study summaries need more than plain language to be effective
Intercept’s NASH drug may need time to meet sky-high sales predictions if approved
Intercept’s OCA may finally secure an FDA approval in NASH, but biopsies and side-effect issues will still haunt early uptake.
Industry 4.0: The revolution investors cannot ignore
[caption id="attachment_2047" align="alignnone" width="658"] Industry 4.0 has seen robotics increase in manufacturing, meaning countries with low labour costs may be...